Citigroup Maintains Neutral on Chemours, Raises Price Target to $21

Citigroup maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $14 to $21.

Benzinga · 11/06/2019 13:17

Citigroup maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $14 to $21.